These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Hormones in cancer chemotherapy. Kennedy BJ Proc Natl Cancer Conf; 1970; 6():627-32. PubMed ID: 5458126 [No Abstract] [Full Text] [Related]
4. [Hormonal aspects and hormone therapy of cancer]. Klijn JG Ned Tijdschr Geneeskd; 1991 Dec; 135(50):2369-75. PubMed ID: 1749441 [No Abstract] [Full Text] [Related]
5. [Medical treatment of malignant bone tumors (carcinolytics, hormonotherapy, immunotherapy)]. Clavel B Sem Hop; 1974 Jan; 50(4):287-95. PubMed ID: 4368180 [No Abstract] [Full Text] [Related]
6. [Hormonal treatment of metastatic bone cancer]. Tubiana-Hulin M Rev Rhum Mal Osteoartic; 1990 Nov; 57(11):821-7. PubMed ID: 2291074 [No Abstract] [Full Text] [Related]
7. [Influence of hormones on prostatic, mammary, endometrial and thyroid tissues]. Franchimont P Rev Med Liege; 1973 Oct; 28(19):659-62. PubMed ID: 4797548 [No Abstract] [Full Text] [Related]
8. Hormones in advanced cancer. Br Med J; 1971 Jun; 2(5764):760-3. PubMed ID: 4253671 [No Abstract] [Full Text] [Related]
9. [Tumors and hormones]. Fujimori M; Abe C Naika; 1967 Mar; 19(3):415-20. PubMed ID: 6063270 [No Abstract] [Full Text] [Related]
10. [Antineoplastic chemotherapies (including hormone therapy). Classification and mechanism of action]. Clavel M Rev Prat; 1991 Dec; 41(26):2759-65. PubMed ID: 1808694 [No Abstract] [Full Text] [Related]
11. Endocrine therapies in breast and prostate cancer. Cancer Treat Res; 1988; 39():1-156. PubMed ID: 2908601 [No Abstract] [Full Text] [Related]
12. [Treatment of prostatic, corpus uteri and kidney neoplasms (hypernephromas) in general practice]. Obrecht JP; Mayr AC; Nagel G Schweiz Med Wochenschr; 1973 Oct; 103(41):1414-21. PubMed ID: 4751562 [No Abstract] [Full Text] [Related]
13. [The contribution of hormone therapy (single or combined) to the prognosis of solid tumors]. Longueville J Rev Med Liege; 1984 Feb; 39(3):108-10. PubMed ID: 6718862 [No Abstract] [Full Text] [Related]
14. [Cytostatic agents and cytostatic therapy]. Host H Tidsskr Nor Laegeforen; 1973 Sep; 93(26):1857-62. PubMed ID: 4767918 [No Abstract] [Full Text] [Related]
15. [Mechanism and side effect of endocrine therapy]. Tsuda M; Ishiguro H; Saji S Nihon Rinsho; 2015 Feb; 73 Suppl 2():291-7. PubMed ID: 25831770 [No Abstract] [Full Text] [Related]
16. Steroid hormone receptors in the regulation of differentiation. A review. McCarty KS; McCarty KS Am J Pathol; 1977 Mar; 86(3):705-44. PubMed ID: 190892 [No Abstract] [Full Text] [Related]
17. The current status of cancer chemotherapy for selected human neoplasms. Rubin RN Clin Ther; 1981; 4(2):74-94. PubMed ID: 7028265 [No Abstract] [Full Text] [Related]
18. Tamoxifen: an overview of recent studies in the field of oncology. Patterson JS; Battersby LA Cancer Treat Rep; 1980; 64(6-7):775-8. PubMed ID: 7000349 [TBL] [Abstract][Full Text] [Related]
19. [Chemotherapy of malignant tumors]. Bollag W Sven Farm Tidskr; 1966 May; 70(13):319-27. PubMed ID: 5960586 [No Abstract] [Full Text] [Related]
20. [The present position of hormone treatment of metastasizing cancer diseases]. Martz G Praxis; 1967 Nov; 56(48):1625-9. PubMed ID: 5632548 [No Abstract] [Full Text] [Related] [Next] [New Search]